Axogen Inc (NASDAQ:AXGN) does about 571.14K shares in volume on a normal day but saw 841859 shares change hands in the recent trading day. The company now has a market cap of 486.41M USD. Its current market price is $10.68, marking an increase of 2.59% compared to the previous close of $10.41. The 52 week high reached by this stock is $21.00 whilst the lowest price level in 52 weeks is $6.59.
The consensus objective for the share price is $24.25, suggesting that the stock has a potential upside of 55.96% over the period.
FactSet Research has provided data showing that 1 brokerages have issued ratings for the stock. 0 analysts have rated it as a sell, while 0 advise that it is a overweight. 1 analysts have rated it as a buy and 0 have advised that investors hold their positions. The consensus recommendation rating is Buy and Wall Street’s advice is for investors to Strong Buy the stock.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on March 17, 2025 when Lake Street initiated the stock to “Buy” and issued a price target of $30. Jefferies resumed its price target at $15.
The current price level is -4.27%, -23.77%, and -29.64% away from its SMA20, SMA50, and SMA200 respectively, with the AXGN price moving above the 50-day SMA on current market day. Axogen Inc (AXGN) stock is down -5.99% over the week and -6.03% over the past month. Its price is -35.19% year-to-date and 51.70% over the past year.
To reach the target analysts have set, the stock logically needs to grow 55.96 percent from here.
Outstanding shares total 45.51M with insiders holding 4.84% of the shares and institutional holders owning 86.30% of the company’s common stock. The company has a return on investment of -4.17% and return on equity of -7.22%. The forward price to earnings ratio is 22.49. The beta has a value of 1.05. Price to book ratio is 4.61 and price to sales ratio is 2.50.
